Table 1 Demographic and clinical information for patients with PD and healthy controls
From: Automatic analysis of eyelid movement in de-novo Parkinson’s disease
PD (n = 120, 39 women) | HC (n = 55, 19 women) | p-value | t-value | |
|---|---|---|---|---|
General | ||||
Age (years) | 60.0 (11.5, 36–83) | 60.4 (9.6, 37–81) | 0.82 | −0.23 |
Sex Ratio | 0.68 | 0.65 | – | – |
Symptom duration (years) | 1.9 (1.8, 0.3–11.3) | – | – | – |
Motor Manifestations | ||||
MDS-UPDRS III score | 29.0 (11.8, 6–63) | 3.6 (3.4, 0–13) | <0.001 | 15.67 |
MDS-UPDRS 3.2, Facial Item | 1.5 (0.81, 0–3) | 0.24 (0.43, 0–1) | <0.001 | 11.25 |
Non-Motor Manifestations | ||||
MoCA | 24.9 (3.8, 15–30) | 26.3 (1.9, 23–30) | <0.01 | −2.80 |
Neuroimaging (DAT-SPECT) | ||||
Mean Putamen SBR | 1.47 (0.34, 0.80–2.49) | – | – | – |
Mean Posterior Putamen SBR | 1.02 (0.30, 0.52–2.17) | – | – | – |
Putamen % interhemispheric Difference | 0.18 (0.11, 0–0.5) | – | – | – |
Posterior Putamen interhemispheric % Difference | 0.26 (0.15, 0–0.65) | – | – | – |
